Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1959)	1/22/1998 4:02:00 PM
From: Tokyo VD	Read Replies (1) \| Respond to of 7041

Bill, I'll answer for the good doctor since he has run off to see patients. Dr. Keith is a young man (mid 30s) with two hospital affiliations: Cabrini Medical Center (CMC) and Beth Israel Health Care Center. CMC is a 493-bed acute care community-based teaching hospital sponsored by the Missionary Sisters of the Sacred Heart of Jesus located in the Gramercy Park section of Manhattan. Dr. Keith is a board certified doctor of internal medicine in good standing at both CMC and Beth Israel. He went to the University of Miami for his medical school training, but decided to come to the Big Apple for his residency (which he completed at CMC). I believe he's been in NYC since 1989, but affiliated with CMC's staff since 1992. Maybe Linda can walk over to his office on E. 12th Street and ask the good doctor why he has chosen to involve himself with Zonagen. Tokyo

To: Bill Wexler who wrote (1959)	1/22/1998 4:43:00 PM
From: troy halle	Respond to of 7041

Bill Im thinking about doubling up on my one share and go to two. and then I will sell them to you for a nickle if your still buying.

To: Bill Wexler who wrote (1959)	1/22/1998 7:23:00 PM
From: Dr. Voodoo	Read Replies (1) \| Respond to of 7041

Bill, Found interesting wording in this press release.(Business Wire, today) Is this what you mean by backing away quietly? Zonagen, Inc. (NASDAQ:ZONA)(PCX:ZNG), located in The Woodlands, is a biopharmaceutical company engaged in the research,development and marketing ofproducts for conditions and diseases associated with the human reproductive system.Zonagen's lead product candidate, Vasomax(TM), is an oral pill treatment for male erectile dysfunction. The company also is developing new approaches to contraception, including zona pellucida-based vaccines in collaboration with Schering AG, treatments for urological diseases such as benign prostatic hyperplasia and prostate cancer, and an adjuvant to enhance the effectiveness of vaccines. Zonagen markets and distributes a variety of third-party fertility-related products through its wholly owned subsidiary, Fertility Technologies, Inc. Leading sponsors of the Texas conference are Arthur Andersen, Andrews & Kurth, Business Wire,Frost Bank, Gerard Klauer Mattison, PPD Pharmaco, Silicon Valley Bank, Willis Corroon of Texas, and Wilson Sonsini Goodrich.